Embolic agents used for uterine fibroid embolization

American Journal of Roentgenology

Volumn 175, Issue 3, 2000, Pages 767-773

  Siskin, G P ^a   Englander, M ^a   Stainken, B F ^a   Ahn, J ^a   Dowling, K ^a   Dolen, E G ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELFOAM; POLYVINYL ALCOHOL;

ARTIFICIAL EMBOLISM; CLINICAL FEATURE; DEVICE; FEMALE; HUMAN; PRIORITY JOURNAL; REVIEW; SYMPTOM; TREATMENT INDICATION; TREATMENT OUTCOME; UTERUS MYOMA;

EID: 0033862751     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.175.3.1750767     Document Type: Review

References (75)

1. Uterine artery embolization for fibroid disease
2. Arterial embolization to treat uterine myomata
3. Preliminary experience with uterine artery embolization for uterine fibroids
4. Uterine arterial embolization for the management of leiomyomas: Quality-of-life assessment and clinical response
5. Initial results from uterine fibroid embolization for symptomatic leiomyomata
6. Uterine artery embolization for the treatment of uterine leiomyomata: Midterm results
7. Comparison of uterine artery embolization for fibroids using gelatin sponge-pledgets and polyvinyl alcohol
8. Use of an absorbable embolic material for arterial embolization therapy for uterine leiomyomas: Midterm results on symptoms and volume of leiomyomas
9. Plastic sponge prosthesis for use after pneumonectomy: Preliminary report
10. Experimental studies on synthetic substitutes for skin and their use in the treatment of burns
11. Ivalon-sponge wrap operation for rectal prolapse: Experience with 26 patients
12. Late complication after plastic reconstruction of outflow tract in tetrology of Fallot
13. Therapeutic transcatheter arterial embolization
14. Polyvinyl alcohol (Ivalon): A new embolic material
15. Polyvinyl alcohol particle size and suspension characteristics
16. Polyvinyl alcohol (Ivalon) as an embolization agent
17. Histopathological follow-up study of 66 cerebral arteriovenous malformations after therapeutic embolization with polyvinyl alcohol
18. Polyvinyl foam embolization of vascular and neoplastic lesions of the head, neck, and spine
19. Angiodysplasia of the right colon treated by embolization with lvalon (polyvinyl alcohol)
20. Particle embolization for hepatocellular carcinoma
21. Bone metastases from renal cell carcinoma: Preoperative embolization
22. Long-term histopathologic follow-up of bronchial arteries after therapeutic embolization with polyvinyl alcohol (Ivalon) in patients with cystic fibrosis
23. Embolization therapy in two subtypes of priapism
24. Internal iliac artery embolization to control hemorrhage from pelvic neoplasms
25. Pregnancy after transcatheter embolization of a uterine arteriovenous malformation
26. An experimental study of embolic effect according to infusion rate and concentration of suspension in transarterial particulate embolization
27. Histopathologic analysis of intraarterial polyvinyl alcohol microemboli in rat cerebral cortex
28. Experimental observations on short and long-term effects of arterial occlusion with Ivalon
29. Therapeutic embolization with long-term occluding agents and their effects on embolized tissues
30. Histopathologic appearance of arterial occlusions with hydrogel and polyvinyl alcohol embolic material in domestic swine
31. Histopathologic long-term follow-up after embolization with polyvinyl alcohol particles
32. Pathologic findings in a uterine leiomyoma after bilateral uterine artery embolization
33. Visualization of injected embolic material (polyvinyl alcohol) in paraffin sections with Verhoeff-van Gieson elastic stain
34. Transarterial embolization of the uterine arteries: Patient reactions and effects on uterine vasculature
35. Nasopharyngeal angiofibromas: Hazards of embolization
36. Control of massive hemoptysis by embolization of intercostal arteries
37. Paresis following internal iliac artery embolization
38. Transcatheter embolization of pelvic vessels for control of intractable hemorrhage
39. Mortalities associated with use of a commercial suspension of polyvinyl alcohol
40. The embolised fibroid uterus
41. A clinical failure of uterine fibroid embolization due to adenomyosis
42. Ovarian artery supply of uterine fibroids as a cause of treatment failure after uterine artery embolization: A case report
43. Fatal septicemia after fibroid embolization
44. Transcervical expulsion of a fibroid as a result of uterine artery embolization for leiomyomata
45. Gelatin sponge in therapeutic neuroradiology: A subject review
46. Certain properties of a new physiologically absorbable sponge
47. Present status of gelatin sponge for the control of hemorrhage
48. Internal occlusion of a carotid-cavernous fistula
49. Percutaneous transfemoral renal artery occlusion in patients with renal carcinoma
50. Selective intraarterial embolization of bone tumors
51. Transcatheter therapeutic arterial embolization
52. Iatrogenic hemobilia: Management with transarterial embolization using Gelfoam particles
53. Hemorrhage associated with pelvic fractures: Causes, diagnosis, and emergent management
54. Transcatheter arterial embolization for control of persistent massive puerperal hemorrhage after bilateral surgical hypogastric artery ligation
55. Obstetric hemorrhage: Prophylactic and emergency arterial catheterization and embolotherapy
56. Obstetric and nonmalignant gynecologic bleeding: Treatment with angiographic embolization
57. Obstetric embolotherapy: Effect on menses and pregnancy
58. Selective vascular embolization in benign gynecologic conditions
59. Pelvic arteriography in obstetrics and gynecology: Arteriovenous fistulas and embolization
60. Cervical ectopic pregnancy: Results of conservative treatment
61. Therapeutic embolization for intractable chronic bleeding
62. Transcatheter occlusion of abdominal tumors
63. Surgical investigation of new absorbable sponge derived from gelatin for use in hemostasis
64. Long-term follow-up of transcatheter embolization with autologous clot, oxycel, and Gelfoam in domestic swine
65. Gelfoam embolization of the left gastric artery for bleeding ulcer: Experimental considerations
66. Complications from the use of absorbable hemostatic sponges
67. Effects of experimental hepatic artery embolization on hepatic function
68. Transcatheter Gelfoam embolization in abdominal retroperitoneal, and pelvic hemorrhage
69. Bladder necrosis secondary to pelvic artery embolization: Case report and literature review
70. Uterine artery embolization: An underused method of controlling pelvic hemorrhage
71. Angiographic embolization in the management of hemorrhagic complications of pregnancy
72. Pelvic abscess complicating embolic therapy for control of bleeding cervical carcinoma and simultaneous radiation therapy
73. Complications associated with transcatheter arterial embolization for hepatic tumors
74. Pregnancy after uterine artery embolization to control hemorrhage from gestational trophoblastic tumour
75. Transcatheter arterial embolization of obstetric and gynecological bleeding: Efficacy and clinical outcome